Cargando…
Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice
Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation. Nevertheless, the risk of QT prolongation due...
Autores principales: | Choi, Byung Jin, Koo, Yeryung, Kim, Tae Young, Chung, Wou Young, Jung, Yun Jung, Park, Ji Eun, Lim, Hong-Seok, Park, Bumhee, Yoon, Dukyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994840/ https://www.ncbi.nlm.nih.gov/pubmed/33767276 http://dx.doi.org/10.1038/s41598-021-86321-z |
Ejemplares similares
-
Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data
por: Choi, Byung Jin, et al.
Publicado: (2022) -
Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment
por: Koo, Yeryung, et al.
Publicado: (2023) -
Development of a Risk Score for QT Prolongation in the Intensive Care Unit Using Time-Series Electrocardiogram Data and Electronic Medical Records
por: Kim, Tae Young, et al.
Publicado: (2021) -
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
por: Choi, Young, et al.
Publicado: (2018) -
Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)